Skip to content
Preprint · CC-BY via OpenAlex

Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin

Miguel Martín‐Pérez, Takashi K. Ito, Anthony S. Grillo, Anthony S. Valente, Jeehae Han, Samuel W. Entwisle, Heather Z Huang, Dayae Kim, Masanao Yajima, Matt R. Kaeberlein, Judit Villén

bioRxiv (Cold Spring Harbor Laboratory) · 2019 · ▲ 5 citations

Abstract

Abstract Leigh syndrome is a fatal neurometabolic disorder caused by defects in mitochondrial function. mTOR(definition) inhibition with rapamycin(definition) attenuates disease progression in a mouse model of Leigh syndrome (Ndufs4 KO mouse); however, the mechanism of rescue is unknown. Here we assessed the impact of rapamycin on the brain proteome and phosphoproteome of Ndufs4 KO mice. We report that rapamycin remodels the brain proteome to alter mitochondrial structure, inhibits signaling through both mTOR complexes, and inhibits multiple protein kinase C (PKC) isoforms. Administration of PKC inhibitors was sufficient to increase survival, delay neurological deficits, and prevent hair loss in Ndufs4 KO mice. Thus, PKC may be a viable therapeutic target for treating severe mitochondrial disease. One Sentence Summary Proteomic and phosphoproteomic analysis of mouse brain identifies PKC as a key target to treat mitochondrial disease

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1101/562207
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Martín‐Pérez, M., Ito, T.K., Grillo, A.S., Valente, A.S., Han, J., Entwisle, S.W., Huang, H.Z., Kim, D., Yajima, M., Kaeberlein, M.R., &amp; Villén, J. (2019). Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/562207
Vancouver
Martín‐Pérez M, Ito TK, Grillo AS, Valente AS, Han J, Entwisle SW, et al. Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin. bioRxiv (Cold Spring Harbor Laboratory). 2019. doi:10.1101/562207.
BibTeX
@unpublished{miguel2019Protei, title = {Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin}, author = {Miguel Martín‐Pérez and Takashi K. Ito and Anthony S. Grillo and Anthony S. Valente and Jeehae Han and Samuel W. Entwisle and Heather Z Huang and Dayae Kim and Masanao Yajima and Matt R. Kaeberlein and Judit Villén}, journal = {bioRxiv (Cold Spring Harbor Laboratory)}, year = {2019}, doi = {10.1101/562207}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings